Arthur L. Goldstein

Art Goldstein is the retired Chairman, President, and Chief Executive Officer of Ionics, Incorporated, a world-renowned business and technology pioneer in the field of water purification. During his 32 years as CEO, Art led Ionics in its growth from a small R&D company to its position as the world leader in water desalination, purification and supply with over 4000 installations in 62 countries and 3,000 employees. General Electric purchased Ionics in early 2005 for $1.3 billion.

Art is a member of the National Academy of Engineering. He is a trustee as well as the Treasurer and Chairman of the Finance Committee of Partners HealthCare System. He is a senior trustee at the California Institute of Technology, a trustee of the Massachusetts General Physicians Organization, an advisory council member of the Harvard Medical School-Partners HealthCare Center for Genetics and Genomics, and a member of the MIT Energy Initiative External Advisory Board. In addition, Art is a director of Cabot Corporation and A123Systems, Inc. He previously served as director of State Street Corporation, director and Chairman of the Massachusetts High Technology Council, director of Jobs for Massachusetts, trustee of Dana-Farber/Partners Cancer Care, member of the Visiting Committees at the Harvard Business School and the Harvard School of Public Health, and as president of the Rensselaer Council.

Art is the holder of 18 U.S. patents in areas relating to the purification and processing of liquids. He received a BS in chemical engineering from Rensselaer Polytechnic Institute, an MS in chemical engineering from the University of Delaware, and an MBA from Harvard University.